Short-term consequences of continuous renal replacement therapy on body composition and metabolic status in sepsis

Asia Pacific Journal of Clinical Nutrition

Volumn 25, Issue 2, 2016, Pages 300-307

  Wu, Chao ^a   Wang, Xinying ^a   Yu, Wenkui ^a   Li, Pei ^b   Liu, Sitong ^b   Li, Jieshou ^a   Li, Ning ^a  

^a NANJING UNIVERSITY   (China)

^b JINLING HOSPITAL   (China)

Author keywords

Body composition; Continuous renal replacement therapy; Intensive care unit; Metabolic state; Sepsis

Indexed keywords

BODY COMPOSITION; BODY WATER; ENERGY METABOLISM; FEMALE; HUMAN; IMPEDANCE; INDIRECT CALORIMETRY; INTENSIVE CARE; MALE; METABOLISM; MIDDLE AGED; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; SEPSIS;

BODY COMPOSITION; BODY WATER; CALORIMETRY, INDIRECT; CRITICAL CARE; ELECTRIC IMPEDANCE; ENERGY METABOLISM; FEMALE; HUMANS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PROSPECTIVE STUDIES; RENAL REPLACEMENT THERAPY; SEPSIS;

EID: 84979096925     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: 10.6133/apjcn.2016.25.2.29     Document Type: Article

References (38)

1. Bone RC, Sibbald CL, Sprung WJ. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest. 1992; 101:1481-3. doi: 10.1378/chest.101.6.1481.
2. Alves-Filho JC, Freitas A, Souto FO, Spiller F, Paula-Neto H, Silva JS et al. Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med. 1996;334: 1697-702. doi: 10.1056/NEJM199606273342603.
3. Bone RC, Grodzin CJ, Balk RA. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest. 1997;112: 235-43. doi: 10.1378/chest.112.1.235.
4. Cohen J. The immunopathogenesis of sepsis. Nature. 2002; 420:885-91. doi: 10.1038/nature01326.
5. Adib-Conquy M, Cavaillon JM. Compensatory antiinflammatory response syndrome. Thromb Haemost. 2009; 101:36-47. doi: 10.1160/TH08-07-0421.
6. Alves-Filho JC, Freitas A, Souto FO, Spiller F, Paula-Neto H, Silva JS, Gazzinelli RT, Teixeira MM, Ferreira SH, Cunha FQ. Regulation of chemokine receptor by Toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis. Proc Natl Acad Sci. 2009;106:4018-23 doi: 10.1073/pnas.0900196106.
7. Turnbull IR, Clark AT, Stromberg PE, Dixon DJ, Woolsey CA, Davis CG, Hotchkiss RS, Buchman TG, Coopersmith CM. Effects of aging on the immunopathologic response to sepsis. Crit Care Med. 2009;37:1018-23. doi: 10.1097/CCM. 0b013e3181968f3a.
8. Bone RC. The pathogenesis of sepsis. Ann Intern Med. 1991;115:457-67. doi: 10.7326/0003-4819-115-6-457.
9. Adib-Conquy M, Cavaillon JM. Compensatory antiinflammatory response syndrome. Thromb Haemost. 2009; 101:36-47. doi: 10.1160/TH08-07-0421.
10. Fiaccadori E, Cremaschi E, Regolisti G. Nutritional assessment and delivery in renal replacement therapy patients. Semin Dial. 2011;24:169-75. doi: 10.1111/j.1525-139X. 2011.00831.x.
11. Chua HR, Xiang L, Chow PY, Xu H, Shen L, Lee E, Teo BW. Quantifying acute changes in volume and nutritional status during haemodialysis using bioimpedance analysis. Nephrology (Carlton). 2012;17:695-702. doi: 10.1111/j. 1440-1797.2012.01653.x.
12. Yu SJ, Kim DH, Oh DJ, Yu SH, Kang ET. Assessment of fluid shifts of body compartments using both bioimpedance analysis and blood volume monitoring. J Korean Med Sci. 2006;21:75-80.doi: 10.3346/jkms.2006.21.1.75
13. Jaeger JQ, Ravindra LM. Assessment of dry weight in hemodialysis: an overview. J Am Soc Nephrol. 1999;10:392-403.
14. Nescolarde L, Donate T, Piccoli A, Rosell J. Comparison of segmental with whole-body impedance measurements in peritoneal dialysis patients. Med Eng Phys. 2008;30:817-24. doi: 10.1016/j.medengphy.2007.09.002.
15. Petros S, Engelmann L. Enteral nutrition delivery and energy expenditure in medical intensive care patients. Clin Nutr. 2006;25:51-9. doi:10.1016/j.clnu.2005.08.013.
16. Alberda C, Gramlich L, Jones N, Jeejeebhoy K, Day AG, Dhaliwal R, Heyland DK. The relationship between nutritional intake and clinical outcomes in critically ill patients: results of an international multicenter observational study. Intensive Care Med. 2009;35:1728-37. doi:10.1007/s00134-009-1620-3.
17. McEvoy CT, Cran GW, Cooke SR, Young IS. Resting energy expenditure in non-ventilated non-sedated patients recovering from serious traumatic brain injury: comparison of prediction equations with indirect calorimetry. Clin Nutr. 2009;28:526-32. doi:10.1016/j.clnu.2009.04.009.
18. Ismael S, Savalle M, Trivin C, Gillaizeau F, D'Auzac C, Faisy C. The consequences of sudden fluid shifts on body composition in critically ill patients. Crit Care. 2014;18:R49. doi: 10.1186/cc13794.
19. Wabel P, Moissl U, Chamney P, Jirka T, Machek P, Ponce P et al. Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload. Nephrol Dial Transplant. 2008;23:2965-71. doi: 10.1093/ndt/gfn228.
20. Ronco C, Brendolan A, Lonnemann G, Bellomo R, Piccinni P, Digito A et al. A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med. 2002;30: 1250-5. doi: 10.1097/00003246-200206000-00015.
21. Rogiers P, Zhang H, Smail N, Pauwels D, Vincent JL. Continuous veno-venous hemofiltration improves cardiac performance by mechanism other than tumor necrosis factor alpha attenuation during endotoxic shock. Crit Care Med. 1999;27:1848-55. doi: 10.1097/00003246-199909000-0002 4.
22. Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P. High-volume hemofiltration in human septicshock. Intens Care Med. 2001;27:978-86. doi: 10.1186/cc37 34.
23. Stack AG, Saran R. Clinical correlates and mortality impact of left ventricular hypertrophy among new ESRD patients in the United States. Am J Kidney Dis. 2002;40:1202. doi: 10. 1053/ajkd.2002.36881.
24. Machek P, Jirka T, Moissl U, Chamney P, Wabel P. Guided optimization of fluid status in haemodialysis patients. Nephrol Dial Transplant. 2010;25:538-44. doi: 10.1093/ndt/gfp48 7.
25. Haider AW, Larson MG, Benjamin EJ, Levy D. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol. 1998;32: 1454 doi: 10.1016/S0735-1097(98)00407-0.
26. Ellis KJ. Human body composition: in vivo methods. Physiol Rev. 2000;80:649-80. doi: Human body composition: in vivo methods.
27. Savalle M, Gillaizeau F, Maruani G, Puymirat E, Bellenfant F, Houillier P, Fagon JY, Faisy C. Assessment of body cell mass at bedside in critically ill patients. Am J Physiol EndocrinolMetab. 2012;303:E389-96. doi: 10.1152/ajpendo.0050 2.2011.
28. Magnuson B, Peppard A, Auer Flomenhoft D. Hypocaloric considerations in patients with potentially hypometabolic disease States. Nutr Clin Pract. 2011;26:253-60. doi: 10.117 7/0884533611405673.
29. RENAL Replacement Therapy Study Investigators, Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S et al. Intensity of continuous renal replacement therapy in critically ill patients. N Engl J Med. 2009;361:1627-38. doi: 10.1056/NE JMoa0902413.
30. Bellomo R, Ronco C. Continuous versus intermittent renal replacement therapy in the intensive care unit. Kidney Int Suppl. 1998;66:S125-8.
31. Btaiche IF, Mohammad RA, Alaniz C, Mueller BA. Amino acid requirements in critically ill patients with acute kidney injury treated with continuous renal replacement therapy. Pharmacotherapy. 2008;28:600-13. doi: 10.1592/phco.28.5.6 00.
32. Susla GM. The impact of continuous renal replacement therapy on drug therapy. Clin Pharmacol Ther. 2009;86:562-5. doi: 10.1038/clpt.2009.152.
33. Oda S, Sadahiro T, Hirayama Y, Nakamura M, Watanabe E, Tateishi Y, Hirasawa H. Non-renal indications for continuous renal replacement therapy: current status in Japan. Contrib Nephrol. 2010;166:47-53. doi: 10.1159/000314851.
34. Goldstein SL. Continuous renal replacement therapy: mechanism of clearance, fluid removal, indications and outcomes. Curr Opin Pediatr. 2011;23:181-5. doi: 10.1097/MOP.0b013 e328342fe67.
35. Tetta C, Mariano F, Buades J, Ronco C, Wratten ML, Camussi G. Relevance of platelet-activating factor in inflammation and sepsis: mechanisms and kinetics of removal in extracorporeal treatments. Am J Kidney Dis. 1997;30(Suppl 4):S57-65. doi: 10.1016/S0272-6386(97)90543-6.
36. Nakao T, Kanazawa Y, Nagaoka Y, Iwasawa H, Uchinaga A, Matsumoto H, Okada T, Yoshino M. Body protein index based on bioelectrical impedance analysis is a useful new marker assessing nutritional status: applications to patients with chronic renal failure on maintenance dialysis. Contrib Nephrol. 2007;155:18-28. doi: 10.1159/000100993.
37. Ronco C, Bellomo R, Kellum JA. Continuous renal replacement therapy: opinions and evidence. Adv Ren Replace Ther. 2002;9:229-44. doi: 10.1053/jarr.2002.35561.
38. Honoré PM, De Waele E, Jacobs R, Mattens S, Rose T, Joannes-Boyau O et al. Nutritional and metabolic alterations during continuous renal replacement therapy. Blood Purif. 2013;35:279-84. doi: 10.1159/000350610.